SLNCF: Silence Therapeutics plc Stock

by  •  • Comments Off on SLNCF: Silence Therapeutics plc Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 1,008.84
Enterprise Value ($M) 943.95
Book Value ($M) 112.74
Book Value / Share 0.80
Price / Book 8.95
NCAV ($M) 97.23
NCAV / Share 0.69
Price / NCAV 10.38

Profitability (mra)
Return on Invested Capital (ROIC) -0.63
Return on Assets (ROA) -0.37
Return on Equity (ROE) -0.58

Liquidity (mrq)
Quick Ratio 8.81
Current Ratio 8.81

Balance Sheet (mrq) ($M)
Current Assets 169.79
Assets 185.30
Liabilities 72.56
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 43.26
Operating Income -49.58
Net Income -45.31

Cash Flow Statement (mra) ($M)
Cash From Operations -67.64
Cash from Investing -21.97
Cash from Financing 142.09

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
9 days ago 13G/A Redmile Group, LLC 4.70 -7.68
05-08 13D/A Griffiths Richard Ian 23.20 6.40
02-11 13G/A Lombard Odier Asset Management (USA) Corp 7.60 34.05
11-14 13G/A Deep Track Capital, LP 2.14 -48.76

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-05-08 10-Q The Group has incurred recurring losses since inception, including net losses of $28.5 million for the three months ended March 31, 2025. As of March 31, 2025, the Group had accumulated losses of $502.5 million and cash outflows from operating activi
2025-04-30 10-K/A PART III PART IV

(click for more detail)

Similar Companies
SGFEF – Siegfried Holding AG SIGO – Sunset Island Group, Inc.
SKVI – Skinvisible, Inc. SMFL – Smart for Life, Inc.
SNNC – Sibannac, Inc.


Financial data and stock pages provided by
Fintel.io